Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown

被引:213
作者
Castillo, I
Pardo, M
Bartolomé, J
Ortiz-Movilla, N
Rodríguez-Iñigo, E
de Lucas, S
Salas, C
Jiménez-Heffernan, JA
Pérez-Mota, A
Graus, J
López-Alcorocho, JM
Carreño, V
机构
[1] Fdn Estudio Hepatitis Virales, Madrid 28015, Spain
[2] Clin Puerta Hierro, Dept Pathol, Madrid, Spain
[3] Hosp Zarzuela, Dept Pathol, Madrid, Spain
[4] Hosp Virgen Torre, Digest Dept, Madrid, Spain
关键词
D O I
10.1086/380202
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. There are patients in whom the etiology of long-standing abnormal results of liver-function tests is unknown (ALF-EU) after exclusion of all known causes of liver diseases. We analyzed the presence of hepatitis C virus (HCV) RNA in liver-biopsy specimens from 100 patients who were negative for anti-HCV antibodies and for serum HCV RNA and who had ALF-EU. Methods. HCV RNA status was tested by reverse-transcription polymerase chain reaction (RT-PCR) and by in situ hybridization, in liver and peripheral-blood mononuclear cells (PBMCs). Results. HCV RNA was detected in liver-biopsy specimens from 57 of 100 patients negative for anti-HCV antibodies and for serum HCV RNA (i.e., who had occult HCV infection). HCV RNA of negative polarity was found in the liver of 48 (84.2%) of these 57 patients with occult HCV infection. Nucleotide-sequence analysis confirmed the specificity of detection of HCV RNA and that patients were infected with the HCV 1b genotype. Of these 57 patients with intrahepatic HCV RNA, 40 (70%) had viral RNA in their PBMCs. With regard to liver histology, patients with occult HCV infection were more likely to have necroinflammatory activity (P=.017) and fibrosis (P = .022) than were patients without intrahepatic HCV RNA. Conclusion. Patients with ALF-EU may have intrahepatic HCV RNA in the absence of anti-HCV antibodies and of serum HCV RNA.
引用
收藏
页码:7 / 14
页数:8
相关论文
共 33 条
  • [21] Use and interpretation of virological tests for hepatitis C
    Pawlotsky, JM
    [J]. HEPATOLOGY, 2002, 36 (05) : S65 - S73
  • [22] Induction of interleukin-12 production in chronic hepatitis C virus infection correlates with the hepatocellular damage
    Quiroga, JA
    Martín, J
    Navas, S
    Carreño, V
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (01) : 247 - 251
  • [23] Histological damage in chronic hepatitis C is not related to the extent of infection in the liver
    Rodríguez-Iñigo, E
    Bartolomé, J
    de Lucas, S
    Manzarbeitia, F
    Pardo, M
    Arocena, C
    Gonsálvez, J
    Oliva, H
    Carreno, V
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (06) : 1877 - 1881
  • [24] Rodríguez-Iñigo E, 2000, J MED VIROL, V60, P269, DOI 10.1002/(SICI)1096-9071(200003)60:3&lt
  • [25] 269::AID-JMV4&gt
  • [26] 3.0.CO
  • [27] 2-1
  • [28] Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3
    Rubbia-Brandt, L
    Quadri, R
    Abid, K
    Giostra, E
    Malé, PJ
    Mentha, G
    Spahr, L
    Zarski, JP
    Borisch, B
    Hadengue, A
    Negro, F
    [J]. JOURNAL OF HEPATOLOGY, 2000, 33 (01) : 106 - 115
  • [29] Demonstration and distribution of HCV RNA sequences by in situ hybridization and HCV-related proteins by immunohistochemistry in the liver tissue of patients with chronic HCV infection
    Sansonno, D
    Cornacchiulo, V
    Iacobelli, AR
    Gatti, P
    DiStasi, M
    Dammacco, F
    [J]. PATHOBIOLOGY, 1995, 63 (05) : 239 - 248
  • [30] STRUCTURE AND ORGANIZATION OF THE HEPATITIS-C VIRUS GENOME ISOLATED FROM HUMAN CARRIERS
    TAKAMIZAWA, A
    MORI, C
    FUKE, I
    MANABE, S
    MURAKAMI, S
    FUJITA, J
    ONISHI, E
    ANDOH, T
    YOSHIDA, I
    OKAYAMA, H
    [J]. JOURNAL OF VIROLOGY, 1991, 65 (03) : 1105 - 1113